Nature Medicine, Published online: 27 June 2025; doi:10.1038/s41591-025-03767-8
Advances in beta cell differentiation have propelled cell therapies for diabetes into the clinic; this Review outlines the lessons learned from early-phase trials and discusses the clinical, manufacturing and regulatory challenges that must now be overcome.
